NCT01428440View on ClinicalTrials.gov

PET Study to Study Tumour Apoptosis

PHASE2TerminatedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Cancer
Interventions
RADIATION

18FML10

apoptosis imaging radio ligand

Trial Locations (2)

W12 0NN

GSK Investigational Site, London

SE1 9RT

GSK Investigational Site, London

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
collaborator

Guy's and St Thomas' NHS Foundation Trust

OTHER

collaborator

Imperial College London

OTHER

lead

GlaxoSmithKline

INDUSTRY

NCT01428440 - PET Study to Study Tumour Apoptosis | Biotech Hunter | Biotech Hunter